SPDR® S&P Biotech ETF

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).

The current price of XBI ETF is 84.74 USD — it has increased by 0.06% in the past 24 hours. Watch XBI ETF price performance more closely on the advanced chart.

XBI ETF has increased by 2.00% in the past week, has increased by 0.59% in the past month, and has decreased by -9.18% in the past year. See more data on XBI ETF chart.

As of 09 Jul 2025, the largest holdings include Exelixis Inc, Alnylam Pharmaceuticals Inc, Moderna Inc, United Therapeutics Corporation, Regeneron Pharmaceuticals Inc, Neurocrine Biosciences Inc. See the full list of XBI ETF holdings.

The XBI ETF consists of 100 holdings, including Exelixis Inc, Alnylam Pharmaceuticals Inc, Moderna Inc and others. See the full list of XBI ETF holdings.

As of 09 Jul 2025, the XBI ETF consists of 100 holdings. See the full list of XBI ETF holdings.

The XBI ETF sectors include Healthcare, Basic Materials, Consumer Cyclical, Financial Services, Real Estate and more.

The easiest way to buy XBI ETF is through an online broker. Some of the popular names are Vanguard, Fidelity, Schwab. Simply open an account, follow the procedures, and start trading. Alternatively, you can practice trading ETFs on Profit.com in Playtrade Tournaments or choose a recommended broker to trade directly.